Informações bibliográficas
DiretrizWHO guidelines on leishmaniases: treatment of visceral leishmaniasis and post-kala-azar dermal leishmaniasis in eastern Africa and South-East Asia
Ano de publicação2026
Instituição emissoraWorld Health Organization
Recomendação
Nova
Post-kala-azar dermal leishmaniasis (PKD)L in South-East Asia. A combination of Liposomal amphotericin B (LAmB) (total dose, 20 mg/kg administered IV on days 1, 4, 8, 11 and 15) plus miltefosine (allometric dose orally BID for 21 days) or LAmB monotherapy (total dose, 20 mg/kg administered IV on days 1, 4, 8, 11 and 15) is suggested for the treatment of PKDL.
Recomendado a favor
Condicional
Certeza da evidência
Muito baixa